Pharma

Your Article Summary

See Latest Articles

Ipsen and GTx Enter into Partnership Agreement for The European Rights of Acapodene(R)
Corporate News Releases - The Healthcare Sales & Marketing Network, 09/08/06

Ipsen, a European pharmaceutical group and GTx, Inc., the Men's Health Biotech Company announced that they have entered into a definitive agreement under which Ipsen will have an exclusive license to develop and market GTx's Acapodene (toremifene citrate) in all indications except breast cancer, in Europe (European Union, Switzerland, Norway, Iceland, Lichtenstein and the Commonwealth of Independent States) ("European Territory")

Today in M&A/Partnerships...keeping you current

Receive free subspecialty "5-minute updates" via email

Novartis inaugurates large-scale US based cell-culture influenza vaccine manufacturing facility
Novartis, 11/25/09

Gilead and GlaxoSmithKline Announce Agreement to Commercialize Viread(R) for Chronic Hepatitis B in Key Asian Countries
Gilead, 11/25/09

Harris Corp. Buys VA Contractor
HealthDataManagement, 11/23/09

 See all of M&A/Partnerships

Today in Marketing/Media/ROI...keeping you current

Receive free subspecialty "5-minute updates" via email

Chugai Revises Corporate Advertisement for First Time in Four Years
Chugai Pharmaceutical Co., 11/25/09

Boston Scientific Announces FDA Clearance and CE Mark for WallFlex Fully Covered Esophageal Stent
Boston Scientific, 11/24/09

Medtronic Introduces 3D Recon Service to Enhance Endovascular Treatment of Aortic Aneurysms
Medtronic, 11/20/09

 See all of Marketing/Media/ROI